1. Home
  2. AMPG vs MCRB Comparison

AMPG vs MCRB Comparison

Compare AMPG & MCRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Amplitech Group Inc.

AMPG

Amplitech Group Inc.

N/A

Current Price

$3.40

Market Cap

51.7M

ML Signal

N/A

Logo Seres Therapeutics Inc.

MCRB

Seres Therapeutics Inc.

N/A

Current Price

$5.11

Market Cap

47.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
AMPG
MCRB
Founded
2002
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
51.7M
47.4M
IPO Year
2012
2015

Fundamental Metrics

Financial Performance
Metric
AMPG
MCRB
Price
$3.40
$5.11
Analyst Decision
Strong Buy
Buy
Analyst Count
1
2
Target Price
$7.00
$14.00
AVG Volume (30 Days)
2.2M
58.5K
Earning Date
05-14-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
69.44
N/A
EPS
N/A
N/A
Revenue
$25,195,930.00
$789,000.00
Revenue This Year
$102.41
N/A
Revenue Next Year
$20.00
N/A
P/E Ratio
N/A
N/A
Revenue Growth
164.99
N/A
52 Week Low
$1.64
$4.32
52 Week High
$10.11
$29.98

Technical Indicators

Market Signals
Indicator
AMPG
MCRB
Relative Strength Index (RSI) 37.20 48.84
Support Level $2.68 $4.59
Resistance Level $4.15 $5.65
Average True Range (ATR) 0.29 0.26
MACD -0.04 0.10
Stochastic Oscillator 9.40 72.46

Price Performance

Historical Comparison
AMPG
MCRB

About AMPG Amplitech Group Inc.

AmpliTech Group Inc designs, develops, engineers, and assembles micro-wave component-based amplifiers that meet individual customer specifications. It operates in two segments: the manufacturing and engineering segment. The products of the company consist of RF amplifiers & related subsystems, operating at multiple frequencies from 50kHz to 44GHz, including Low Noise Amplifiers, Medium Power Amplifiers, cryogenic amplifiers, and custom assemblies. The company also offers non-recurring engineering services on a project-by-project basis, for a predetermined fixed contractual amount, or on a time-plus-material basis. It also operates as a manufacturer, & distributor of cryogenic microwave amplifiers, RF designs, & applications for Wireless Networks & the future of Wireless Communication.

About MCRB Seres Therapeutics Inc.

Seres Therapeutics Inc is a clinical-stage biotechnology company focused on the development of live biotherapeutic candidates. Its pipeline includes candidates such as SER-155 and SER-603, aimed at preventing and treating bacterial infections, antimicrobial resistance, and gastrointestinal immune diseases. The company operates as a single reportable segment, mainly developing microbiome-based therapies targeting bacterial infections, antimicrobial resistance, and gastrointestinal immune diseases.

Share on Social Networks: